Skip to content

Conservative Treatment of Trigger Finger

Conservative Treatment of Trigger Finger: Outcomes of a Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05837286
Enrollment
146
Registered
2023-05-01
Start date
2023-08-01
Completion date
2026-05-31
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Injuries, Trigger Finger

Brief summary

This study is to analyze the effectiveness of a nighttime extension orthosis after receiving a cortisone injection for the treatment of trigger finger to improve pain and restore functional outcomes. The investigators hypothesize that the extension orthosis will improve pain and functional outcomes compared to those without a digital night extension orthosis in those with trigger finger at 12 weeks from the injection.

Detailed description

The purpose of the research is to analyze the effectiveness of a proximal interphalangeal joint (PIPJ) extension night orthosis status-post cortisone injection of the first annular pulley for the treatment of trigger finger to improve pain and restore functional outcomes. The investigators hypothesize that the extension orthosis will improve pain and functional outcomes (Quick Dash score) compared to those without a digital night extension orthosis in those with trigger finger at 12 weeks from the injection.

Interventions

DEVICEOval-8 ® Orthosis

The experimental group will consist of receiving a PIP joint on the day they receive their cortisone injection. The Oval-8 ® will be issued to the subject by an Occupational Therapist to ensure correct fit and comfort as well as given written instructions for night use. The orthosis will be worn at night for 6-week duration. Participants will have 1 follow up phone call or email at the 6-week mark and then 1 follow up phone call or email at the 12 week mark by a member of the research team from the time they received their cortisone injection where the time for resolution of trigger finger symptoms, VAS (Visual Analogue Scale), subjective questionnaire and QuickDASH scores will all be recorded in their medical research file.

OTHERCortisone injection only

The control group will receive a cortisone injection and be instructed to move their fingers normally

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking

Intervention model description

The primary objective of this study is to analyze the effectiveness of a nighttime PIP joint extension orthosis to improve pain and restore functional outcomes in TF and comparing two groups of participants with TF, one group receiving a cortisone injection only and the experimental group receiving the nighttime orthosis after cortisone injection using the QuickDASH.

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Individuals 18 years old or older are included * Patients with trigger finger, aka stenosing flexor tenosynovitis * Status post receiving cortisone injection of the affected digit(s)

Exclusion criteria

* Any records flagged with break the glass or research opt out * Patients with rheumatoid arthritis * Patients with a history of traumatic injury to the hand * Cognitive or behavioral problems which would preclude informed consent * Unable to speak and understand English

Design outcomes

Primary

MeasureTime frameDescription
Resolution of Trigger Finger Symptoms6 WeeksQuestionnaire used to determine resolution of Trigger Finger Symptoms

Secondary

MeasureTime frameDescription
Change in Pain6 weeksVisual Analogue Scale for Pain (0 pain free to 10 severe pain)
Change in Perception of Function12 weeksQuickDash scores (0% no functional limitations to 100% disabled)

Countries

United States

Contacts

CONTACTTheodore Brown, BS
Theodore.Brown@cshs.org800-700-6424
CONTACTMeghan McCullough, MD
Meghan.McCullough@cshs.org
PRINCIPAL_INVESTIGATORMeghan McCullough, MD

Cedars-Sinai Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026